KYORIN Pharmaceutical Co., Ltd. (TYO:4569)
Japan · Delayed Price · Currency is JPY 1,181.00
+4.00 (0.34%)
Jul 14, 2026, 3:30 PM JST
KYORIN Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 13, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 67,859 | 94,499 | 86,288 | 104,097 | 97,646 | 101,826 | |
Market Cap Growth | -20.24% | 9.52% | -17.11% | 6.61% | -4.11% | -7.83% |
Enterprise Value | 76,563 | 106,074 | 103,362 | 105,733 | 99,919 | 92,413 |
Last Close Price | 1181.00 | 1645.00 | 1449.70 | 1686.23 | 1541.68 | 1559.85 |
PE Ratio | 19.68 | 27.41 | 9.50 | 19.56 | 20.68 | 25.90 |
Forward PE | 43.74 | 20.76 | 20.70 | 17.98 | 18.11 | 30.61 |
PS Ratio | 0.54 | 0.75 | 0.66 | 0.87 | 0.86 | 0.97 |
PB Ratio | 0.48 | 0.66 | 0.63 | 0.80 | 0.78 | 0.82 |
P/TBV Ratio | 0.49 | 0.68 | 0.66 | 0.83 | 0.81 | 0.84 |
P/FCF Ratio | 26.96 | 37.54 | - | - | - | 26.10 |
P/OCF Ratio | 10.63 | 14.81 | 24.61 | 67.20 | 48.63 | 16.05 |
PEG Ratio | - | 9.56 | 9.56 | 9.56 | 9.56 | 9.56 |
EV/Sales Ratio | 0.61 | 0.84 | 0.80 | 0.89 | 0.88 | 0.88 |
EV/EBITDA Ratio | 9.33 | 12.98 | 6.03 | 10.27 | 11.15 | 10.60 |
EV/EBIT Ratio | 21.60 | 30.23 | 8.24 | 17.61 | 19.51 | 18.47 |
EV/FCF Ratio | 30.42 | 42.14 | - | - | - | 23.68 |
Debt / Equity Ratio | 0.17 | 0.17 | 0.21 | 0.16 | 0.17 | 0.17 |
Debt / EBITDA Ratio | 2.91 | 2.91 | 1.66 | 2.03 | 2.37 | 2.48 |
Debt / FCF Ratio | 9.45 | 9.45 | - | - | - | 5.54 |
Net Debt / Equity Ratio | 0.06 | 0.06 | 0.09 | 0.05 | 0.02 | -0.05 |
Net Debt / EBITDA Ratio | 1.07 | 1.07 | 0.70 | 0.68 | 0.21 | -0.67 |
Net Debt / FCF Ratio | 3.46 | 3.46 | -5.44 | -1.65 | -0.44 | -1.50 |
Asset Turnover | 0.65 | 0.65 | 0.70 | 0.68 | 0.65 | 0.62 |
Inventory Turnover | 1.12 | 1.12 | 1.18 | 1.34 | 1.40 | 1.39 |
Quick Ratio | 2.12 | 2.12 | 1.82 | 1.36 | 1.91 | 2.15 |
Current Ratio | 4.60 | 4.60 | 3.88 | 2.62 | 3.40 | 3.62 |
Return on Equity (ROE) | 2.47% | 2.47% | 6.80% | 4.15% | 3.78% | 3.16% |
Return on Assets (ROA) | 1.13% | 1.13% | 4.22% | 2.12% | 1.84% | 1.85% |
Return on Invested Capital (ROIC) | 1.80% | 1.82% | 6.24% | 3.44% | 2.85% | 3.22% |
Return on Capital Employed (ROCE) | 2.10% | 2.10% | 7.90% | 4.50% | 3.60% | 3.60% |
Earnings Yield | 5.08% | 3.65% | 10.53% | 5.11% | 4.84% | 3.86% |
FCF Yield | 3.71% | 2.66% | -2.54% | -4.06% | -4.43% | 3.83% |
Dividend Yield | 2.12% | 3.46% | 3.59% | 3.08% | 3.37% | 3.33% |
Payout Ratio | 95.79% | 95.80% | 33.18% | 56.61% | 63.84% | 95.80% |
Buyback Yield / Dilution | 0.00% | 0.00% | -0.10% | -0.15% | -0.00% | -0.01% |
Total Shareholder Return | 2.12% | 3.47% | 3.48% | 2.93% | 3.37% | 3.32% |